123 related articles for article (PubMed ID: 34126807)
1. Assessing the Applicability of the TALK Score: A Modification for Concurrent Tobacco Use During Treatment.
Johnson M; Porterfield JZ; Kejner AE
Otolaryngol Head Neck Surg; 2022 Feb; 166(2):282-288. PubMed ID: 34126807
[TBL] [Abstract][Full Text] [Related]
2. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
3. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
[TBL] [Abstract][Full Text] [Related]
4. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
[TBL] [Abstract][Full Text] [Related]
5. Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population.
Marruecos-Querol J; Rubió-Casadevall J; Lozano A; Buxó M; Puigdemont M; Linares I; Planas I; Vayreda J; Cirauqui B; Taberna M; Quiroga V; Tobed M; Borés A; Recalde S; Saigi M; Felip E; Eraso A; Mesía R
Clin Transl Oncol; 2023 Aug; 25(8):2384-2392. PubMed ID: 36943650
[TBL] [Abstract][Full Text] [Related]
6. Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?
Al-Mamgani A; Navran A; Walraven I; Schreuder WH; Tesselaar MET; Klop WMC
Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):575-583. PubMed ID: 30564952
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Dietz A; Wichmann G; Kuhnt T; Pfreundner L; Hagen R; Scheich M; Kölbl O; Hautmann MG; Strutz J; Schreiber F; Bockmühl U; Schilling V; Feyer P; de Wit M; Maschmeyer G; Jungehülsing M; Schroeder U; Wollenberg B; Sittel C; Münter M; Lenarz T; Klussmann JP; Guntinas-Lichius O; Rudack C; Eich HT; Foerg T; Preyer S; Westhofen M; Welkoborsky HJ; Esser D; Thurnher D; Remmert S; Sudhoff H; Görner M; Bünzel J; Budach V; Held S; Knödler M; Lordick F; Wiegand S; Vogel K; Boehm A; Flentje M; Keilholz U
Ann Oncol; 2018 Oct; 29(10):2105-2114. PubMed ID: 30412221
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
9. Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
Guadagnolo BA; Haddad RI; Posner MR; Weeks L; Wirth LJ; Norris CM; Sullivan CA; Goguen L; Busse PM; Tishler R
Am J Clin Oncol; 2005 Aug; 28(4):371-8. PubMed ID: 16062079
[TBL] [Abstract][Full Text] [Related]
10. Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.
Bonner J; Giralt J; Harari P; Spencer S; Schulten J; Hossain A; Chang SC; Chin S; Baselga J
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):842-9. PubMed ID: 27389475
[TBL] [Abstract][Full Text] [Related]
11. Metabolic tumor volume of primary tumor predicts survival better than T classification in the larynx preservation approach.
Miyabe J; Hanamoto A; Tatsumi M; Hamasaki T; Takenaka Y; Nakahara S; Kishikawa T; Suzuki M; Takemoto N; Michiba T; Yoshioka Y; Isohashi F; Konishi K; Ogawa K; Hatazawa J; Inohara H
Cancer Sci; 2017 Oct; 108(10):2030-2038. PubMed ID: 28787757
[TBL] [Abstract][Full Text] [Related]
12. Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer.
Petersen JF; Arends CR; van der Noort V; Al-Mamgani A; de Boer JP; Stuiver MM; van den Brekel MWM
Oral Oncol; 2019 Aug; 95():143-149. PubMed ID: 31345382
[TBL] [Abstract][Full Text] [Related]
13. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
14. The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008).
Zhu J; Fedewa S; Chen AY
Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1120-8. PubMed ID: 23247231
[TBL] [Abstract][Full Text] [Related]
15. Modified TALK Score for Japanese Patients with Laryngeal and Hypopharyngeal Cancers to Predict the Possibility of Laryngeal Preservation by Concurrent Chemoradiotherapy.
Otsuki N; Matsui M; Takahashi M; Sasaki R; Kiyota N; Usami M; Nibu KI
Kobe J Med Sci; 2018 Apr; 63(4):E113-E122. PubMed ID: 29955023
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for pharyngocutaneous fistulization after total laryngectomy.
Timmermans AJ; Lansaat L; Theunissen EA; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
Ann Otol Rhinol Laryngol; 2014 Mar; 123(3):153-61. PubMed ID: 24633941
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome following total laryngectomy for cancer.
Hall FT; O'Brien CJ; Clifford AR; McNeil EB; Bron L; Jackson MA
ANZ J Surg; 2003 May; 73(5):300-5. PubMed ID: 12752286
[TBL] [Abstract][Full Text] [Related]
18. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
Dziegielewski PT; O'Connell DA; Klein M; Fung C; Singh P; Alex Mlynarek M; Fung D; Harris JR; Seikaly H
J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S56-64. PubMed ID: 22569051
[TBL] [Abstract][Full Text] [Related]
19. Primary organ preservation vs total laryngectomy for T4a larynx cancer.
Oh J; Prisman E; Olson R; Berthelet E; Wu J; Tran E; Bakos B; Kaviani R; Hamilton SN
Head Neck; 2019 Sep; 41(9):3265-3275. PubMed ID: 31215719
[TBL] [Abstract][Full Text] [Related]
20. Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome.
Basheeth N; O'Leary G; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):790-6. PubMed ID: 23949354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
